person · Reporting owner

Carestio Daniel A

Disclosed activity across 2 companies

Tapewire entity: 40499
SEC CIK: 0001651806

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
STERIS plcSTE · Entity 3228	Director · President and CEO	June 04, 2026	June 08, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

STERIS plc

Report date June 04, 2026 · Filed June 08, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	Direct	68,075	Reported balance After 2026-06-04 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2026-06-04 · Tax withholding · Disposed 1,889 · Balance 68,075 F1: 1,889 shares were withheld from the 4,283 restricted shares that vested on June 4, 2026. These 1,889 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 4, 2026.
Ordinary SharesSEC Table I · non-derivative	Direct	65,021	Reported balance After 2026-06-04 transaction · row 2 Account or security details depend on footnotes; rows are not merged. 1 source row Row 2 · 2026-06-04 · Sale · Disposed 3,054 · Balance 65,021
Ordinary SharesSEC Table I · non-derivative	Direct	63,647	Reported balance After 2026-06-05 transaction · row 3 Account or security details depend on footnotes; rows are not merged. 1 source row Row 3 · 2026-06-05 · Sale · Disposed 1,374 · Balance 63,647 F2: As of June 8, 2026, 39,893 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,912 on June 2, 2027; 5,937 on June 3, 2027; 4,283 on June 4, 2027; 7,912 on June 2, 2028; 5,937 on June 5, 2028 and 7,912 on June 4, 2029.

Filing footnotes · ownership attribution and instrument terms

F1: 1,889 shares were withheld from the 4,283 restricted shares that vested on June 4, 2026. These 1,889 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 4, 2026.

F2: As of June 8, 2026, 39,893 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,912 on June 2, 2027; 5,937 on June 3, 2027; 4,283 on June 4, 2027; 7,912 on June 2, 2028; 5,937 on June 5, 2028 and 7,912 on June 4, 2029.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

STERIS plc

Report date March 28, 2019 · Filed March 28, 2019

Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Ordinary Shares, 10 pence par valueSEC Table I · non-derivative	Direct	Reported balance After 2019-03-28 transaction · row 1 1 source row Row 1 · 2019-03-28 · Disposition to issuer · Disposed 20,460 · Balance 0 F1: 20,460 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,000 on May 28, 2019; 2,500 on June 1, 2020; 3,000 on October 1, 2019; 5,500 on June 1, 2021; 2,712 on May 31, 2022 and 1,748 on October 3, 2022. F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.52 · Expires 2024-05-30	Direct	Reported balance After 2019-03-28 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2019-03-28 · Disposition to issuer · Disposed 7,000 · Balance 0 F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $67.98 · Expires 2025-08-10	Direct	Reported balance After 2019-03-28 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2019-03-28 · Disposition to issuer · Disposed 8,000 · Balance 0 F4: This option will become exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 8,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $69.72 · Expires 2026-06-01	Direct	Reported balance After 2019-03-28 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2019-03-28 · Disposition to issuer · Disposed 15,000 · Balance 0 F5: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.07 · Expires 2027-05-30	Direct	Reported balance After 2019-03-28 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2019-03-28 · Disposition to issuer · Disposed 18,000 · Balance 0 F6: This option becomes exercisable as follows: 4,500 on May 30, 2018; 4,500 on May 30, 2019; 4,500 on June 1, 2020 and 4,500 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 18,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.22 · Expires 2028-05-31	Direct	Reported balance After 2019-03-28 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2019-03-28 · Disposition to issuer · Disposed 29,864 · Balance 0 F7: This option becomes exercisable as follows: 7,466 on May 31, 2019; 7,466 on June 1, 2020; 7,466 on June 1, 2021 and 7,466 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 29,864 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $125.58 · Expires 2028-10-01	Direct	Reported balance After 2019-03-28 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2019-03-28 · Disposition to issuer · Disposed 9,468 · Balance 0 F8: This option becomes exercisable as follows: 2,367 shares on October 1, 2019; 2,367 shares on October 1, 2020; 2,367 shares on October 1, 2021 and 2,367 shares on October 3, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 9,468 ordinary shares of STERIS for $125.58 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

Filing footnotes · ownership attribution and instrument terms

F1: 20,460 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,000 on May 28, 2019; 2,500 on June 1, 2020; 3,000 on October 1, 2019; 5,500 on June 1, 2021; 2,712 on May 31, 2022 and 1,748 on October 3, 2022.

F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.

F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 7,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F4: This option will become exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 8,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F5: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F6: This option becomes exercisable as follows: 4,500 on May 30, 2018; 4,500 on May 30, 2019; 4,500 on June 1, 2020 and 4,500 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 18,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F7: This option becomes exercisable as follows: 7,466 on May 31, 2019; 7,466 on June 1, 2020; 7,466 on June 1, 2021 and 7,466 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 29,864 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

F8: This option becomes exercisable as follows: 2,367 shares on October 1, 2019; 2,367 shares on October 1, 2020; 2,367 shares on October 1, 2021 and 2,367 shares on October 3, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 9,468 ordinary shares of STERIS for $125.58 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 05, 2026 Filed Jun 8, 2026 20:31 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	1,374	$212.00	$291,288.00	Disclosure SEC source: 0001628280-26-041629 · wk-form4_1780950690.xml · nonDerivative · entry 3 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,647 F2 · balance_after: As of June 8, 2026, 39,893 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,912 on June 2, 2027; 5,937 on June 3, 2027; 4,283 on June 4, 2027; 7,912 on June 2, 2028; 5,937 on June 5, 2028 and 7,912 on June 4, 2029. Read SEC document
June 04, 2026 Filed Jun 8, 2026 20:31 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	3,054	$214.64	$655,510.56	Disclosure SEC source: 0001628280-26-041629 · wk-form4_1780950690.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,021 Read SEC document
June 04, 2026 Filed Jun 8, 2026 20:31 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	1,889	$212.24	$400,921.36	Disclosure SEC source: 0001628280-26-041629 · wk-form4_1780950690.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,075 F1 · shares: 1,889 shares were withheld from the 4,283 restricted shares that vested on June 4, 2026. These 1,889 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 4, 2026. Read SEC document
June 03, 2026 Filed Jun 5, 2026 20:31 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	2,619	$210.19	$550,487.61	Disclosure SEC source: 0001628280-26-041275 · wk-form4_1780691485.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,964 F1 · shares: 2,619 shares were withheld from the 5,937 restricted shares that vested on June 3, 2026. These 2,619 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 3, 2026. F2 · balance_after: As of June 3, 2026, 44,176 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,283 on June 4, 2026; 7,912 on June 2, 2027; 5,937 on June 3, 2027; 4,283 on June 4, 2027; 7,912 on June 2, 2028; 5,937 on June 5, 2028 and 7,912 on June 4, 2029. Read SEC document
June 02, 2026 Filed Jun 4, 2026 20:32 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Option (right to buy) · Derivative	82,740	$0.00 Strike: $230.74	$0.00	Disclosure SEC source: 0001628280-26-040835 · wk-form4_1780605146.xml · derivative · entry 3 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,740 Underlying: Ordinary Shares · 82,740 shares Expires 2036-06-02 F3 · derivative.exercise_date: This option becomes exercisable as follows: 20,685 on June 2, 2027, 20,685 on June 2, 2028, 20,685 on June 4, 2029 and 20,685 on June 3, 2030. Read SEC document
June 02, 2026 Filed Jun 4, 2026 20:32 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	995	$209.76	$208,711.20	Disclosure SEC source: 0001628280-26-040835 · wk-form4_1780605146.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,583 F2 · shares: 995 shares were withheld from the 2,369 restricted shares that vested on June 2, 2026. These 995 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026. F1 · balance_after: As of June 2, 2026, 50,113 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,937 on June 3, 2026; 4,283 on June 4, 2026; 7,912 on June 2, 2027; 5,937 on June 3, 2027; 4,283 on June 4, 2027; 7,912 on June 2, 2028; 5,937 on June 5, 2028 and 7,912 on June 4, 2029. Read SEC document
June 02, 2026 Filed Jun 4, 2026 20:32 UTC	STERIS plc STE · Entity 3228	GrantOrdinary Shares	23,736	$0.00	$0.00	Disclosure SEC source: 0001628280-26-040835 · wk-form4_1780605146.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,578 F1 · balance_after: As of June 2, 2026, 50,113 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,937 on June 3, 2026; 4,283 on June 4, 2026; 7,912 on June 2, 2027; 5,937 on June 3, 2027; 4,283 on June 4, 2027; 7,912 on June 2, 2028; 5,937 on June 5, 2028 and 7,912 on June 4, 2029. Read SEC document
June 01, 2026 Filed Jun 3, 2026 20:39 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	1,254	$0.00	$0.00	Disclosure SEC source: 0001628280-26-040430 · wk-form4_1780519171.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,842 F1 · shares: 1,254 shares were withheld from the 4,308 restricted shares that vested on June 1, 2026. These 1,254 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 · balance_after: As of June 1, 2026, 28,746 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,937 on June 3, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026; 5,937 on June 3, 2027; 4,283 on June 4, 2027; and 5,937 on June 5, 2028. Read SEC document
October 06, 2025 Filed Oct 8, 2025 20:34 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	159	$241.82	$38,449.38	Disclosure SEC source: 0001628280-25-044614 · wk-form4_1759955658.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,096 F1 · balance_after: As of October 6, 2025, 33,054 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,308 on June 1, 2026; 5,937 on June 3, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026; 5,937 on June 3, 2027; 4,283 on June 4, 2027; and 5,937 on June 5, 2028. Read SEC document
October 01, 2025 Filed Oct 3, 2025 20:48 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	130	$0.00	$0.00	Disclosure SEC source: 0001628280-25-044114 · wk-form4_1759524525.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,255 F1 · shares: 130 shares were withheld from the 289 restricted shares that vested on October 1, 2025. These 130 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 289 ordinary shares were awarded to Mr. Carestio on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 1, 2025. F2 · balance_after: As of October 1, 2025, 33,054 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,308 on June 1, 2026; 5,937 on June 3, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026; 5,937 on June 3, 2027; 4,283 on June 4, 2027; and 5,937 on June 5, 2028. Read SEC document
June 05, 2025 Filed Jun 6, 2025 20:30 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	5,126	$243.49	$1,248,129.74	Disclosure SEC source: 0001628280-25-030023 · wk-form4_1749241830.xml · nonDerivative · entry 4 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,385 F2 · balance_after: As of June 4, 2025, 33,343 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 1, 2025; 4,308 on June 1, 2026; 5,937 on June 3, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026; 5,937 on June 3, 2027; 4,283 on June 4, 2027; and 5,937 on June 5, 2028. Read SEC document
June 05, 2025 Filed Jun 6, 2025 20:30 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	4,980	$242.67	$1,208,496.60	Disclosure SEC source: 0001628280-25-030023 · wk-form4_1749241830.xml · nonDerivative · entry 3 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,511 F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $242.39 to $243.07 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: As of June 4, 2025, 33,343 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 1, 2025; 4,308 on June 1, 2026; 5,937 on June 3, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026; 5,937 on June 3, 2027; 4,283 on June 4, 2027; and 5,937 on June 5, 2028. Read SEC document
June 05, 2025 Filed Jun 6, 2025 20:30 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	7,520	$241.85	$1,818,712.00	Disclosure SEC source: 0001628280-25-030023 · wk-form4_1749241830.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,491 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $241.33 to $242.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: As of June 4, 2025, 33,343 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 1, 2025; 4,308 on June 1, 2026; 5,937 on June 3, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026; 5,937 on June 3, 2027; 4,283 on June 4, 2027; and 5,937 on June 5, 2028. Read SEC document
June 04, 2025 Filed Jun 6, 2025 20:30 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	1,921	$242.10	$465,074.10	Disclosure SEC source: 0001628280-25-030023 · wk-form4_1749241830.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,011 F1 · shares: 1,921 shares were withheld from the 4,283 restricted shares that vested on June 4, 2025. These 1,921 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,283 ordinary shares were awarded to Mr. Carestio on June 4, 2024. These vested shares were valued at the NYSE closing market price on June 4, 2025. F2 · balance_after: As of June 4, 2025, 33,343 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 1, 2025; 4,308 on June 1, 2026; 5,937 on June 3, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026; 5,937 on June 3, 2027; 4,283 on June 4, 2027; and 5,937 on June 5, 2028. Read SEC document
June 03, 2025 Filed Jun 5, 2025 20:34 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Option (right to buy) · Derivative	63,328	$0.00 Strike: $267.66	$0.00	Disclosure SEC source: 0001628280-25-029680 · wk-form4_1749155573.xml · derivative · entry 2 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,328 Underlying: Ordinary Shares · 63,328 shares Expires 2035-06-03 F2 · derivative.exercise_date: This option becomes exercisable as follows: 15,832 on June 3, 2026, 15,832 on June 3, 2027, 15,832 on June 5, 2028 and 15,832 on June 4, 2029. Read SEC document
June 03, 2025 Filed Jun 5, 2025 20:34 UTC	STERIS plc STE · Entity 3228	GrantOrdinary Shares	17,811	$0.00	$0.00	Disclosure SEC source: 0001628280-25-029680 · wk-form4_1749155573.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,932 F1 · balance_after: As of June 3, 2025, 37,626 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,283 on June 4, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026; 5,937 on June 3, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026; 5,937 on June 3, 2027; 4,283 on June 4, 2027 and 5,937 on June 5, 2028. Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:31 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	708	$242.08	$171,392.64	Disclosure SEC source: 0001628280-25-029347 · wk-form4_1749069063.xml · nonDerivative · entry 3 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,121 F4 · shares: 708 shares were withheld from the 2,369 restricted shares that vested on June 2, 2025. These 708 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,369 ordinary shares were awarded to Mr. Carestio on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 19,815 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,283 on June 4, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026 and 4,283 on June 4, 2027. Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:31 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	452	$242.08	$109,420.16	Disclosure SEC source: 0001628280-25-029347 · wk-form4_1749069063.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,829 F3 · shares: 452 shares were withheld from the 1,514 restricted shares that vested on June 2, 2025. These 452 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,514 ordinary shares were awarded to Mr. Carestio on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 19,815 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,283 on June 4, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026 and 4,283 on June 4, 2027. Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:31 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	1,905	$242.08	$461,162.40	Disclosure SEC source: 0001628280-25-029347 · wk-form4_1749069063.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,281 F1 · shares: 1,905 shares were withheld from the 4,308 restricted shares that vested on June 2, 2025. These 1,905 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,308 ordinary shares were awarded to Mr. Carestio on May 31, 2023. These vested shares were valued at the NYSE closing market price on June 2, 2025. F2 · balance_after: As of June 3, 2025, 19,815 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,283 on June 4, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026 and 4,283 on June 4, 2027. Read SEC document
October 01, 2024 Filed Oct 2, 2024 20:33 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	130	$235.78	$30,651.40	Disclosure SEC source: 0001628280-24-041920 · wk-form4_1727901187.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,186 F1 · shares: 130 shares were withheld from the 289 restricted shares that vested on October 1, 2024. These 130 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 289 ordinary shares were awarded to Mr. Carestio on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 1, 2024. F2 · balance_after: As of October 1, 2024, 28,006 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,308 on June 2, 2025; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 4,283 on June 4, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026 and 4,283 on June 4, 2027. Read SEC document
June 04, 2024 Filed Jun 5, 2024 20:31 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	1,063	$228.37	$242,757.31	Disclosure SEC source: 0001628280-24-026863 · wk-form4_1717619474.xml · nonDerivative · entry 3 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,467 F3 · shares: 1,063 shares were withheld from the 2,369 restricted shares that vested on June 3, 2024. These 1,063 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,369 ordinary shares were awarded to Mr. Carestio on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 3, 2024. F4 · balance_after: As of June 3, 2024, 15,446 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 1, 2024; 4,308 on June 2, 2025; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026 and 2,369 on June 2, 2026. Read SEC document
June 04, 2024 Filed Jun 6, 2024 20:33 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Option (right to buy) · Derivative	81,544	$0.00 Strike: $251.34	$0.00	Disclosure SEC source: 0001628280-24-027064 · wk-form4_1717705976.xml · derivative · entry 2 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,544 Underlying: Ordinary Shares · 81,544 shares Expires 2034-06-04 F2 · derivative.exercise_date: This option becomes exercisable as follows: 20,386 on June 4, 2025; 20,386 on June 4, 2026; 20,386 on June 4, 2027 and 20,386 on June 5, 2028. Read SEC document
June 04, 2024 Filed Jun 6, 2024 20:33 UTC	STERIS plc STE · Entity 3228	GrantOrdinary Shares	12,849	$0.00	$0.00	Disclosure SEC source: 0001628280-24-027064 · wk-form4_1717705976.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,316 F1 · balance_after: As of June 4, 2024, 28,295 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 1, 2024; 4,308 on June 2, 2025; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 4,283 on June 4, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026 and 4,283 on June 4, 2027. Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:31 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	680	$228.37	$155,291.60	Disclosure SEC source: 0001628280-24-026863 · wk-form4_1717619474.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,530 F2 · shares: 680 shares were withheld from the 1,514 restricted shares that vested on June 3, 2024. These 680 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,514 ordinary shares were awarded to Mr. Carestio on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:31 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	480	$228.37	$109,617.60	Disclosure SEC source: 0001628280-24-026863 · wk-form4_1717619474.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,210 F1 · shares: 480 shares were withheld from the 1,108 restricted shares that vested on June 3, 2024. These 480 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,108 ordinary shares were awarded to Mr. Carestio on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 3, 2024. Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:32 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	1,286	$222.88	$286,623.68	Disclosure SEC source: 0001628280-24-026583 · wk-form4_1717533170.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,690 F1 · shares: 1,286 shares were withheld from the 4,308 restricted shares that vested on May 31, 2024. These 1,286 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,308 ordinary shares were awarded to Mr. Carestio on May 31, 2023. These vested shares were valued at the NYSE closing market price on May 31, 2024. F2 · balance_after: As of May 31, 2024, 20,437 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,108 on June 3, 2024; 2,369 on June 3, 2024; 1,514 on June 3, 2024; 289 on October 1, 2024; 4,308 on June 2, 2025; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026 and 2,369 on June 2, 2026. Read SEC document
October 02, 2023 Filed Oct 4, 2023 20:35 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	130	$215.50	$28,015.00	Disclosure SEC source: 0001209191-23-051983 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,976 F1 · shares: 130 shares were withheld from the 289 restricted shares that vested on October 2, 2023. These 130 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 289 ordinary shares were awarded to Mr. Carestio on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 2, 2023. F2 · balance_after: As of October 2, 2023, 24,745 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,308 on May 31, 2024; 1,108 on June 3, 2024; 2,369 on June 3, 2024; 1,514 on June 3, 2024; 289 on October 1, 2024; 4,308 on June 2, 2025; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026 and 2,369 on June 2, 2026. Read SEC document
June 02, 2023 Filed Jun 6, 2023 20:30 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	2,422	$205.47	$497,648.34	Disclosure SEC source: 0001209191-23-034764 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,106 F1 · shares: 2,422 shares were withheld from the 5,397 restricted shares that vested on June 2, 2023. These 2,422 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 5,397 ordinary shares were awarded to Mr. Carestio on June 2, 2021 and June 2, 2022. These vested shares were valued at the NYSE closing market price on June 2, 2023. F2 · balance_after: As of June 2, 2023, 25,034 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 2, 2023; 4,308 on May 31, 2024; 1,108 on June 3, 2024; 2,369 on June 3, 2024; 1,514 on June 3, 2024; 289 on October 1, 2024; 4,308 on June 2, 2025; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026 and 2,369 on June 2, 2026. Read SEC document
June 01, 2023 Filed Jun 5, 2023 20:30 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	1,491	$202.42	$301,808.22	Disclosure SEC source: 0001209191-23-034307 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,528 F1 · shares: 1,491 shares were withheld from the 3,324 restricted shares that vested on June 1, 2023. These 1,491 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 3,324 ordinary shares were awarded to Mr. Carestio on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 1, 2023. F2 · balance_after: As of June 1, 2023, 30,431 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,028 on June 2, 2023; 2,369 on June 2, 2023; 289 on October 2, 2023; 4,308 on May 31, 2024; 1,108 on June 3, 2024; 2,369 on June 3, 2024; 1,514 on June 3, 2024; 289 on October 1, 2024; 4,308 on June 2, 2025; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026 and 2,369 on June 2, 2026. Read SEC document
May 31, 2023 Filed Jun 2, 2023 20:30 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Option (right to buy) · Derivative	89,808	$0.00 Strike: $219.97	$0.00	Disclosure SEC source: 0001209191-23-033761 · doc4.xml · derivative · entry 3 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,808 Underlying: Ordinary Shares · 89,808 shares Expires 2033-05-31 F3 · derivative.exercise_date: This option becomes exercisable as follows: 22,452 on May 31, 2024; 22,452 on June 2, 2025; 22,452 on June 1, 2026 and 22,452 on June 1, 2027. Read SEC document
May 31, 2023 Filed Jun 2, 2023 20:30 UTC	STERIS plc STE · Entity 3228	GrantOrdinary Shares	12,924	$0.00	$0.00	Disclosure SEC source: 0001209191-23-033761 · doc4.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,019 F2 · balance_after: As of May 31, 2023, 33,755 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,324 on June 1, 2023; 3,028 on June 2, 2023; 2,369 on June 2, 2023; 289 on October 2, 2023; 4,308 on May 31, 2024; 1,108 on June 3, 2024; 2,369 on June 3, 2024; 1,514 on June 3, 2024; 289 on October 1, 2024; 4,308 on June 2, 2025; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026 and 2,369 on June 2, 2026. Read SEC document
May 31, 2023 Filed Jun 2, 2023 20:30 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	1,506	$199.97	$301,154.82	Disclosure SEC source: 0001209191-23-033761 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,095 F1 · shares: 1,506 shares were withheld from the 5,008 restricted shares that vested on May 31, 2023. These 1,506 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 5,008 ordinary shares were awarded to Mr. Carestio on May 31, 2019. These vested shares were valued at the NYSE closing market price on May 31, 2023. F2 · balance_after: As of May 31, 2023, 33,755 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,324 on June 1, 2023; 3,028 on June 2, 2023; 2,369 on June 2, 2023; 289 on October 2, 2023; 4,308 on May 31, 2024; 1,108 on June 3, 2024; 2,369 on June 3, 2024; 1,514 on June 3, 2024; 289 on October 1, 2024; 4,308 on June 2, 2025; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026 and 2,369 on June 2, 2026. Read SEC document
October 03, 2022 Filed Oct 5, 2022 20:35 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	914	$170.07	$155,443.98	Disclosure SEC source: 0001209191-22-052762 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,601 F1 · shares: 914 shares were withheld from the 2,037 restricted shares that vested on October 3, 2022. These 914 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,037 ordinary shares were awarded to Mr. Carestio on October 1, 2018 and October 1, 2021. These vested shares were valued at the NYSE closing market price on October 3, 2022. F2 · balance_after: As of October 5, 2022, 25,839 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,008 on May 31, 2023; 3,324 on June 1, 2023; 3,028 on June 2, 2023; 2,369 on June 2, 2023; 289 on October 2, 2023; 1,108 on June 3, 2024; 2,369 on June 3, 2024; 1,514 on June 3, 2024; 289 on October 1, 2024; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 289 on October 1, 2025 and 2,369 on June 2, 2026. Read SEC document
June 02, 2022 Filed Jun 3, 2022 21:01 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Option (right to buy) · Derivative	79,948	$0.00 Strike: $250.06	$0.00	Disclosure SEC source: 0001209191-22-034183 · doc4.xml · derivative · entry 2 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,948 Underlying: Ordinary Shares · 79,948 shares Expires 2032-06-02 F2 · derivative.exercise_date: This option becomes exercisable as follows: 19,987 on June 2, 2023, 19,987 on June 3, 2024, 19,987 on June 2, 2025 and 19,987 on June 2, 2026. Read SEC document
June 02, 2022 Filed Jun 3, 2022 21:01 UTC	STERIS plc STE · Entity 3228	GrantOrdinary Shares	9,476	$0.00	$0.00	Disclosure SEC source: 0001209191-22-034183 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,515 F1 · shares: As of June 2, 2022, 27,876 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,748 on October 3, 2022; 289 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023; 3,028 on June 2, 2023; 2,369 on June 2, 2023; 289 on October 2, 2023; 1,108 on June 3, 2024; 2,369 on June 3, 2024; 1,514 on June 3, 2024; 289 on October 1, 2024; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 289 on October 1, 2025 and 2,369 on June 2, 2026. F1 · balance_after: As of June 2, 2022, 27,876 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,748 on October 3, 2022; 289 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023; 3,028 on June 2, 2023; 2,369 on June 2, 2023; 289 on October 2, 2023; 1,108 on June 3, 2024; 2,369 on June 3, 2024; 1,514 on June 3, 2024; 289 on October 1, 2024; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 289 on October 1, 2025 and 2,369 on June 2, 2026. Read SEC document
May 31, 2022 Filed Jun 2, 2022 23:00 UTC	STERIS plc STE · Entity 3228	Tax withholdingOrdinary Shares	810	$228.20	$184,842.00	Disclosure SEC source: 0001209191-22-033695 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,039 F1 · shares: 810 shares were withheld from the 2,712 restricted shares that vested on May 31, 2022. These 810 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,712 ordinary shares were awarded to Mr. Carestio on May 31, 2018. These vested shares were valued at the NYSE closing market price on May 31, 2022. F2 · balance_after: 18,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,748 on October 3, 2022; 289 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023; 3,028 on June 2, 2023; 289 on October 2, 2023; 1,108 on June 3, 2024; 1,514 on June 3, 2024; 289 on October 1, 2024; 1,514 on June 2, 2025 and 289 on October 1, 2025. Read SEC document
October 01, 2021 Filed Oct 5, 2021 20:50 UTC	STERIS plc STE · Entity 3228	GrantEmployee Stock Options (right to buy) · Derivative	18,920	$0.00 Strike: $228.36	$0.00	Disclosure SEC source: 0001209191-21-059498 · doc4.xml · derivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,920 Underlying: Ordinary Shares · 18,920 shares Expires 2031-10-01 F3 · derivative.exercise_date: This option becomes exercisable as follows: 4,730 on October 3, 2022; 4,730 on October 2, 2023; 4,730 on October 1, 2024 and 4,730 on October 1, 2025. Read SEC document
October 01, 2021 Filed Oct 5, 2021 20:50 UTC	STERIS plc STE · Entity 3228	GrantOrdinary Shares	1,156	$0.00	$0.00	Disclosure SEC source: 0001209191-21-059498 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,849 F1 · shares: All 1,156 of these ordinary shares are restricted. The restrictions on these shares lapse as follows: 289 on October 3, 2022; 289 on October 2, 2023; 289 on October 1, 2024 and 289 on October 1, 2025. F2 · balance_after: 21,112 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,712 on May 31, 2022; 1,748 on October 3, 2022; 289 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023; 3,028 on June 2, 2023; 289 on October 2, 2023; 1,108 on June 3, 2024; 1,514 on June 3, 2024; 289 on October 1, 2024; 1,514 on June 2, 2025 and 289 on October 1, 2025. Read SEC document
June 02, 2021 Filed Jun 3, 2021 20:35 UTC	STERIS plc STE · Entity 3228	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	59,316	$0.00 Strike: $210.30	$0.00	Disclosure SEC source: 0001209191-21-037670 · doc4.xml · derivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,316 Underlying: Ordinary Shares · 59,316 shares Expires 2031-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option becomes exercisable as follows: 14,829 on June 2, 2022, 14,829 on June 2, 2023, 14,829 on June 3, 2024 and 14,829 on June 2, 2025. Read SEC document
June 02, 2021 Filed Jun 3, 2021 20:35 UTC	STERIS plc STE · Entity 3228	GrantOrdinary Shares	6,056	$0.00	$0.00	Disclosure SEC source: 0001209191-21-037670 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,693 F1 · shares: All 6,056 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,028 on June 2, 2023; 1,514 on June 3, 2024 and 1,514 on June 2, 2025. F2 · balance_after: 19,956 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023, 3,028 on June 2, 2023, 1,108 on June 3, 2024, 1,514 on June 3, 2024 and 1,514 on June 2, 2025. Read SEC document
June 01, 2021 Filed Jun 2, 2021 20:31 UTC	STERIS plc STE · Entity 3228	Disposition to issuerOrdinary Shares	1,677	$188.43	$315,997.11	Disclosure SEC source: 0001209191-21-037194 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,637 F1 · shares: 1,677 shares were withheld from the 5,500 restricted shares that vested on June 1, 2021. These 1,677 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 5,500 ordinary shares were awarded to Mr. Carestio on May 30, 2017. These vested shares were valued at the NYSE closing market price on June 1, 2021. F2 · balance_after: 13,900 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document
October 06, 2020 Filed Oct 8, 2020 20:32 UTC	STERIS plc STE · Entity 3228	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	13,500	$0.00 Strike: $77.07	$0.00	Disclosure SEC source: 0001209191-20-054280 · doc4.xml · derivative · entry 7 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 Underlying: Ordinary Shares · 13,500 shares Expires 2027-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: This option to purchase 18,000 STERIS ordinary shares, of which 13,500 are fully vested and were exercised, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS"), in exchange for an option to purchase 18,000 Old STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document
October 06, 2020 Filed Oct 8, 2020 20:32 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	712	$184.53	$131,385.36	Disclosure SEC source: 0001209191-20-054280 · doc4.xml · nonDerivative · entry 6 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,314 F10 · shares: This exercise of stock options and sale of a total of 712 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F11 · price: Price reflects a weighted average sale price for multiple transactions ranging from $184.30 to $184.85 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document
October 06, 2020 Filed Oct 8, 2020 20:32 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	2,777	$183.67	$510,051.59	Disclosure SEC source: 0001209191-20-054280 · doc4.xml · nonDerivative · entry 5 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,026 F8 · shares: This exercise of stock options and sale of a total of 2,777 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F9 · price: Price reflects a weighted average sale price for multiple transactions ranging from $183.25 to $184.2450 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document
October 06, 2020 Filed Oct 8, 2020 20:32 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	3,444	$182.86	$629,769.84	Disclosure SEC source: 0001209191-20-054280 · doc4.xml · nonDerivative · entry 4 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,803 F6 · shares: This exercise of stock options and sale of a total of 3,444 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F7 · price: Price reflects a weighted average sale price for multiple transactions ranging from $182.2150 to $183.19 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document
October 06, 2020 Filed Oct 8, 2020 20:32 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	2,903	$181.25	$526,168.75	Disclosure SEC source: 0001209191-20-054280 · doc4.xml · nonDerivative · entry 3 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,247 F4 · shares: This exercise of stock options and sale of a total of 2,903 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F5 · price: Price reflects a weighted average sale price for multiple transactions ranging from $181.0050 to $181.8150 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document
October 06, 2020 Filed Oct 8, 2020 20:32 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	3,664	$180.65	$661,901.60	Disclosure SEC source: 0001209191-20-054280 · doc4.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,150 F2 · shares: This exercise of stock options and sale of a total of 3,664 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $180.00 to $180.9850 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document
October 06, 2020 Filed Oct 8, 2020 20:32 UTC	STERIS plc STE · Entity 3228	Exercise / conversionOrdinary Shares	13,500	$77.07	$1,040,445.00	Disclosure SEC source: 0001209191-20-054280 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document
September 18, 2020 Filed Sep 21, 2020 20:38 UTC	STERIS plc STE · Entity 3228	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	15,000	$0.00 Strike: $69.72	$0.00	Disclosure SEC source: 0001209191-20-051291 · doc4.xml · derivative · entry 4 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option to purchase 15,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS"), in exchange for an option to purchase 15,000 Old STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document
September 18, 2020 Filed Sep 21, 2020 20:38 UTC	STERIS plc STE · Entity 3228	SaleOrdinary Shares	206	$176.03	$36,262.18	Disclosure SEC source: 0001209191-20-051291 · doc4.xml · nonDerivative · entry 3 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,314 F4 · shares: This exercise of stock options and sale of a total of 128 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F5 · price: Price reflects a weighted average sale price for multiple transactions ranging from $176.02 to $176.03 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.